Correlation Between Franklin Genomic and Franklin Exponential

Can any of the company-specific risk be diversified away by investing in both Franklin Genomic and Franklin Exponential at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Genomic and Franklin Exponential into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Genomic Advancements and Franklin Exponential Data, you can compare the effects of market volatilities on Franklin Genomic and Franklin Exponential and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Genomic with a short position of Franklin Exponential. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Genomic and Franklin Exponential.

Diversification Opportunities for Franklin Genomic and Franklin Exponential

-0.69

Correlation Coefficient

Franklin Genomic  Franklin Exponential

Excellent diversification

The 3 months correlation between Franklin and Franklin is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Genomic Advancements and Franklin Exponential Data in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Exponential Data and Franklin Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Genomic Advancements are associated (or correlated) with Franklin Exponential. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Exponential Data has no effect on the direction of Franklin Genomic i.e., Franklin Genomic and Franklin Exponential go up and down completely randomly.

Pair Corralation between Franklin Genomic and Franklin Exponential

Given the investment horizon of 90 days Franklin Genomic Advancements is expected to under-perform the Franklin Exponential. In addition to that, Franklin Genomic is 1.16 times more volatile than Franklin Exponential Data. It trades about -0.09 of its total potential returns per unit of risk. Franklin Exponential Data is currently generating about 0.21 per unit of volatility. If you would invest  2,301  in Franklin Exponential Data on August 30, 2024 and sell it today you would earn a total of  354.00  from holding Franklin Exponential Data or generate 15.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Franklin Genomic Advancements  vs.  Franklin Exponential Data

Franklin Genomic Adv

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Franklin Exponential Data

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Exponential Data are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Franklin Exponential unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Franklin Genomic and Franklin Exponential

The main advantage of trading using opposite Franklin Genomic and Franklin Exponential positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Genomic position performs unexpectedly, Franklin Exponential can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Exponential will offset losses from the drop in Franklin Exponential's long position.

The idea behind Franklin Genomic Advancements and Franklin Exponential Data pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.